Zurich Cantonal Bank’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $862K | Buy |
32,545
+2,099
| +7% | +$55.6K | ﹤0.01% | 1319 |
|
|
2025
Q1 | $735K | Buy |
30,446
+3,611
| +13% | +$87.2K | ﹤0.01% | 1366 |
|
|
2024
Q4 | $1.08M | Buy |
26,835
+4,012
| +18% | +$161K | ﹤0.01% | 1145 |
|
|
2024
Q3 | $1.44M | Buy |
22,823
+646
| +3% | +$40.9K | ﹤0.01% | 938 |
|
|
2024
Q2 | $1.18M | Buy |
22,177
+3,755
| +20% | +$199K | ﹤0.01% | 988 |
|
|
2024
Q1 | $1.51M | Sell |
18,422
-1,915
| -9% | -$157K | 0.01% | 862 |
|
|
2023
Q4 | $378K | Buy |
20,337
+3,698
| +22% | +$68.8K | ﹤0.01% | 1692 |
|
|
2023
Q3 | $184K | Buy |
16,639
+4,136
| +33% | +$45.8K | ﹤0.01% | 2019 |
|
|
2023
Q2 | $203K | Buy |
12,503
+3,420
| +38% | +$55.4K | ﹤0.01% | 1917 |
|
|
2023
Q1 | $151K | Buy |
+9,083
| New | +$151K | ﹤0.01% | 2051 |
|
|
2022
Q2 | – | Sell |
-20,294
| Closed | -$61K | – | 2933 |
|
|
2022
Q1 | $61K | Hold |
20,294
| – | – | ﹤0.01% | 2472 |
|
|
2021
Q4 | $93K | Buy |
20,294
+12,145
| +149% | +$55.7K | ﹤0.01% | 2552 |
|
|
2021
Q3 | $51K | Hold |
8,149
| – | – | ﹤0.01% | 2607 |
|
|
2021
Q2 | $49K | Hold |
8,149
| – | – | ﹤0.01% | 2454 |
|
|
2021
Q1 | $52K | Hold |
8,149
| – | – | ﹤0.01% | 2375 |
|
|
2020
Q4 | $46K | Hold |
8,149
| – | – | ﹤0.01% | 2456 |
|
|
2020
Q3 | $47K | Hold |
8,149
| – | – | ﹤0.01% | 2270 |
|
|
2020
Q2 | $59K | Buy |
8,149
+4,210
| +107% | +$30.5K | ﹤0.01% | 2161 |
|
|
2020
Q1 | $18K | Hold |
3,939
| – | – | ﹤0.01% | 2367 |
|
|
2019
Q4 | $32K | Hold |
3,939
| – | – | ﹤0.01% | 2357 |
|
|
2019
Q3 | $27K | Hold |
3,939
| – | – | ﹤0.01% | 2352 |
|
|
2019
Q2 | $33K | Hold |
3,939
| – | – | ﹤0.01% | 2286 |
|
|
2019
Q1 | $39K | Hold |
3,939
| – | – | ﹤0.01% | 2148 |
|
|
2018
Q4 | $30K | Buy |
+3,939
| New | +$30K | ﹤0.01% | 2300 |
|